Ireland
--:--IST
Latest
Clinical Trials in France / NCT06937710
Recruiting Not applicable

Analysis of Biomechanical Parameters and Return to Sport After Hip Arthroscopy

NCT06937710 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-04-17
Last updated
2026-07-09

Condition(s) studied

Hip Arthroscopy

Investigational drug(s) / intervention(s)

Measure of symmetry between the inferior limbs

Measure of symmetry between the inferior limbs: Hip force moments will be analyzed in the 3 planes (in Nm/Kg) and compared between the two legs.

Study summary

The aim of this prospective study is to describe dynamic movement parameters in active patients who underwent surgery between 3 and 6 months after hip arthroscopy, focusing on movements such as jumping, squatting and acceleration. By examining the relationships between these different parameters and the return to sporting activities, and by integrating different angle and alignment measurements per- and post-operatively, we hope to find predictive factors for successive rehabilitation in athletes, which could lead to more personalized rehabilitation protocols.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Hip arthroscopy for labrum lesion * athlete prior to arthroscopy with desire to return to sport Exclusion Criteria: * Previous surgery or pathology of the operated lower limb * Contralateral hip operated * Neurological pathology affecting movement * Medical condition contraindicating participation in sports * Dementia or inability to complete questionnaires and assessments * Pregnant or breast-feeding patient * Patient under protective supervision * Patient not covered by a social security scheme

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinique du Sport Bordeaux Merignac Mérignac France Recruiting

More Clinique du Sport, Bordeaux Mérignac trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06937710 on ClinicalTrials.gov ↗ ← All trials in France